Acupuncture Point Injection of Vitamin K1 to Treat Severe Primary Dysmenorrhea: Case Series at a Women’s Health Service in Bologna
- 1 Family Planning Clinic, Bologna Local Health Unit, Bologna, Italy
- 2 Department of Medical and Surgical Science, University of Bologna, Bologna, Italy
- 3 Gynecology and Pathophysiology of Human Reproduction Unit, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 4 Healthcare and Social Agency of Emilia-Romagna Region, Bologna, Italy
- 5 Family Planning Clinic, Bologna Local Health Unit, Bologna, Italy
Abstract
Introduction and Aim: Vitamin K acupuncture point injection is an effective and safe menstrual pain treatment derived from Traditional Chinese Medicine, commonly used in some Chinese hospitals. This case series investigated the effectiveness and safety of vitamin K acupuncture point injection on menstrual pain in patients with severe primary dysmenorrhea at a regional public health clinic at Bologna, Italy. Methods: From September 2006 to July 2010, 24 women were enrolled and treated during their first day of menstrual pain with an injection of 1 ml of solution containing 5 mg of vitamin K1 in an acupuncture point San Yin Jiao/Spleen 6 (SP6) bilaterally on the inside of each lower leg above the ankle. Results: Treatment was well tolerated and no major adverse events were reported. Pain relief was observed starting from 2 minutes after treatment and within 30 minutes. All treated women but one (96%) reported a substantial pain reduction (p < 0.001). During the six post-treatment follow-up cycles, a trend toward a reduction of menstrual distress evaluated by the Cox Pain Intensity and Duration Scales was documented. Women reported fewer daily life restrictions and consumption of fewer analgesic tablets when compared to what they reported at the pre-treatment cycle. Conclusions: The results of this case series indicate that in primary dysmenorrhea a single vitamin K1 injection in the SP6 acupuncture point has an immediate pain-relieving effect and may ameliorate menstrual pain intensity and duration in post-treatment follow-up cycles.
- Ju, H., Jones, M. and Mishra, G. (2014) The Prevalence and Risk Factors of Dysmenorrheal. Epidemiologic Reviews, 36, 104-113. https://doi.org/10.1093/epirev/mxt009
- Latthe, P., Latthe, M., Say, L., Gülmezoglu, M. and Khan, K.S. (2006) WHO Systematic Review of Prevalence of Chronic Pelvic Pain: A Neglected Reproductive Health Morbidity. BMC Public Health, 6, 177. https://doi.org/10.1186/1471-2458-6-177
- Iacovides, S., Avidon, I. and Baker, F.C. (2015) What We Know about Primary Dysmenorrhoea Today: A Critical Review. Human Reproduction Update, 21, 762-778. https://doi.org/10.1093/humupd/dmv039
- Marjoribanks, J., Proctor, M., Farquhar, C. and Ayeleke, R.O. (2015) Nonsteroidal anti-Inflammatory Drugs for Dysmenorrhoea. The Cochrane Database of Systematic Reviews, 7, CD001751. https://doi.org/10.1002/14651858.CD001751.pub3
- Nor Azlin, M.I., Maryasalwati, I., Norzilawati, M.N., Mahdy, Z.A., Jamil, M.A. and Zainul Rashid, M.R. (2008) The Efficacy of Etoricoxib vs Mefenamic Acid in the Treatment of Primary Dysmenorrhoea: A Randomised Comparative Trial. Journal of Obstetrics and Gynaecology, 28, 424-426. https://doi.org/10.1080/01443610802150051
- Iacovides, S., Baker, F.C. and Avidon, I. (2014) The 24-H Progression of Menstrual Pain in Women with Primary Dysmenorrhea When Given Diclofenac Potassium: A Randomized, Double-Blinded, Placebo-Controlled Crossover Study. Archives of Gynecology and Obstetrics, 289, 993-1002. https://doi.org/10.1007/s00404-013-3073-8
- Daniels, S., Gitton, X., Zhou, W., Stricker, K. and Barton, S. (2008) Efficacy and Tolerability of Lumiracoxib 200 mg once Daily for Treatment of Primary Dysmenorrhoea: Results from Two Randomized Controlled Trials. Journal of Women’s Health, 17, 423-437. https://doi.org/10.1089/jwh.2007.0416
- Daniels, S., Robbins, J., West, C.R. and Nemeth, M.A. (2009) Celecoxib in the Treatment of Primary Dysmenorrhoea: Results from Two Randomized, Double-Blind, Active- and Placebo-Controlled, Crossover Studies. Clinical Therapeutics, 31, 1192-1208.
- Wong, C.L., Farquhar, C., Roberts, H. and Proctor, M. (2009) Oral Contraceptive Pill for Primary Dysmenorrhoea. The Cochrane Database of Systematic Reviews, 4, CD002120. https://doi.org/10.1002/14651858.CD002120.pub3
- Daniels, J.P. and Khan, K.S. (2010) Chronic Pelvic Pain in Women. BMJ, 341, c4834. https://doi.org/10.1136/bmj.c4834
- Vercellini, P., Vigano, P. and Somigliana, E. (2005) The Role of the Levonorgestrel-Releasing Intrauterine Device in the Management of Symptomatic Endometriosis. Current Opinion in Obstetrics and Gynecology, 17, 359-365. https://doi.org/10.1097/01.gco.0000175353.03061.7f